CClinicalTrials.gg
Status unknownNCT03634956Updated Aug 20, 2018

Effect of IONM on Efficacy and Safety Using Sugammadex in Thyroid Surgery

An interventional study of Group B. Sugammadex sodium-IONM in Vocal Cord Paralysis and Recurrent Laryngeal Nerve, sponsored by Lütfiye Nuri Burat Government Hospital. Status unknown at 1 site in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2018-08-20.

Sponsored by Lütfiye Nuri Burat Government Hospital · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Aug 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
2
Allocation
Not applicable
Ages
18 Years to 75 Years
Sex
All
01

Study summary

Thyroidectomy is a frequently performed surgeon by the head and neck and endocrine surgeons. In recent years, surgical techniques and technological developments have resulted in a significant reduction in complication rates. Despite these advances, there is still a great deal of anxiety about the sound problems that can be experienced in patients after surgery. In the past years,the investigators have tried to prevent recurrent nerve paralysis by using intraoperative nerve monitoring (IONM). The use of IONM has begun to be preferred by many surgeons in the investigator's country. However, the use of IONM decreases the number of recurrent nerve paralysis are still being discussed and many studies have been done. In this study, it is aimed to prevent the formation of recurrent nerve paralysis in order to safely carry out the IONM by removing the effects of neuromuscular blockade drugs using sugammadex sodium medicine in the thyroidectomy operations.

Read the detailed description

Patients who will undergo thyroidectomy using the IONM in the General Surgery Clinic of Istanbul, Bakırköy Dr.Sadi Konuk Training and Research Hospital. In this prospective observational clinical trial, the patients will be divided into two groups and the study will be performed as randomize. Randomization Patients who arrive consecutively, will be included in the study group (Group I IONM, group B IONM-sugammadex sodium). In both groups, anesthesia induction should be done with 3 mg / kg propofol, 2 ugr / kg fentanyl, 0.6 mg / kg rocuronium bromide, as the intubation tube, the number appropriate for the patient, After reaching the throat loom, the patient is entrapped and then the operation is started. After reaching the thyroid loin and hanging the throid with the swab sutures, the lobe is taken out with the finger maneuver and then the vascular nerve packet is dissected and the vagal nerve is exposed. IONM(Medtronic-NIM) were detected in the recurrent nerve thyroglossal groove and 100 microvolts or more were measured with nerve monitoring. + Acceptance of resection was started and IONM After the intubation of the group B-sugammadex sodium was started, the left hand ulnar sinus TOF-Guard device was placed and operation started. After reaching the thyroid loops and hanging the throids with hanging sutures and removing the lobe with finger maneuver, the vascular nerve was disassembled and the vagal nerve was dislocated. Then the electrical value was recorded with IONM and sugammadex sodium 2 mg / kg was made. and the TOF response at 4th minute is over 90% of the value to be measured and if the IONM is 100 microvolts higher, the recurrent nerve is found in the troglossal groove and the nerve is followed with the IONM and the resection procedure is started and the tirodidectomy will be performed. V0: vagal nerve initial value; V1: value before troid resection; V2: value after troid resection; R1: value after troid resection, R2: value after troid resection. Preoperative and postoperative vocal cord examination will be examined by otolaryngologist. Size, weight, sex, ASA scores, operation times, complications will be recorded. If there is no signal in RLN with intraoperative IONM and RLN paralysis will be accepted if there is inactivity in the vocal cord at the 1st postoperative ENT specialist vocal cord examinations. RLN paralysis will be accepted if there is inactivity in the cord at the vocal cord examination of the postoperative specialist ENT specialist. The ENT specialist and general surgeon will follow up and if the vocal cord is still in motion, the permanent RLN will be considered a paralysis.

02

Conditions studied

  • Vocal Cord Paralysis
  • Recurrent Laryngeal Nerve

Keywords

  • multinoduler goitre
  • thyroid cancer
  • sugammadex sodium
  • intraoperative nerve monitorization
03

In context

Vocal Cord Paralysis

55 studies on the registry are indexed under Vocal Cord Paralysis; 14 are open to participants now.

This study's planned enrollment of 2 is below the median of 39 across 38 interventional studies indexed under Vocal Cord Paralysis.

Browse Vocal Cord Paralysis studies →

Lead sponsor

Lütfiye Nuri Burat Government Hospital is the lead sponsor of 5 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinical diagnosis of Multinodular goiter,
  • Clinical diagnosis of thyroid cancer
  • Clinical diagnosis of noduler goatr,
  • Clinical diagnosis of basedow Graves disease,

Exclusion criteria

Exclusion Criteria:

  • Patients with bleeding diathesis,
  • Patients who have previously undergone laryngeal surgery (vocal polyps, nodules or laryngeal cancer),
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
2 participants (estimated)

Study arms

  • Experimental
    Group I.IONM in thyroid surgery

    Group I.IONM in thyroid surgery.Once the vagus has been detected,nerve conduction data will be detected with IONM. If the muscle relaxant effect is not detected, it will be detected with TOF device.

    Drug: Group B. Sugammadex sodium-IONM

Interventions

  • DrugGroup B. Sugammadex sodium-IONM

    Group B.the vagal nerve is detected and then 2 mg / kg of sugammadex sodium is administered to remove the muscle relaxant effect

    Also known as: Sugammadex sodium intervention group

06

What researchers measure

Primary outcomes

  1. Vocal cord paralysis

    postoperative vocal cord examination will be performed and the recurrent laryngeal nerve will be examined.

    Time frame: postop 15th days

Secondary outcomes

  1. vagal nerve conduction value(V1)

    V1: value to receive enough nerve conduction for IONM use from the vagus nerve

    Time frame: 15 to 45 minutes of surgery

  2. vagal nerve conduction value after lob resection(V2)

    V2:Vagus value after resection of thyroid lobe

    Time frame: 30 to 90 minutes of surgery

  3. first detected vagal nerve conduction value(V0)

    initial value after vagus sinus is detected

    Time frame: 5 to 25 minutes of surgery

  4. TOF time

    the time that the muscle relaxant is shown by the peripheral nerve stimulator whose effect has disappeared.TOF\>0.9

    Time frame: 10 to 90 minutes of surgery

07

Study locations

1 of 1 sites recruiting
  • Lutfiye NBGH
    İstanbul, 34300, Turkey
    Recruiting
08

References and documents

Publications

  • Empis de Vendin O, Schmartz D, Brunaud L, Fuchs-Buder T. Recurrent Laryngeal Nerve Monitoring and Rocuronium: A Selective Sugammadex Reversal Protocol. World J Surg. 2017 Sep;41(9):2298-2303. doi: 10.1007/s00268-017-4004-9. PubMed 28349321 ↗
  • Barczynski M, Konturek A, Cichon S. Randomized clinical trial of visualization versus neuromonitoring of recurrent laryngeal nerves during thyroidectomy. Br J Surg. 2009 Mar;96(3):240-6. doi: 10.1002/bjs.6417. PubMed 19177420 ↗

Individual participant data

Plan to share: Yes — Patients who are accepted to participate in the study will be gathered in the pool. The patients' data will be entered on the computer. The computer and patients will be randomized and set up on the day of surgery. The preop, perop and postop data of the patients will be recorded on the computer.

Supporting information: Study protocol, Sap, Icf, Csr, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03634956
Lead sponsor
Lütfiye Nuri Burat Government Hospital
Responsible party
TURGUT DONMEZ (Principal investigator, Lütfiye Nuri Burat Government Hospital) — Principal investigator
First posted
Aug 17, 2018
Start date
Aug 14, 2018
Primary completion
Feb 14, 2019 (estimated)
Completion
Mar 14, 2019 (estimated)
Last update
Aug 20, 2018

Study contacts

Turgut Donmez, surgeon
Contact
surgeont73@hotmail.com
+905347400967
Mehmet Emin Gunes, surgeon
Contact
memgunes@hotmail.com
+90532 59943334
Turgut Donmez, surgeon
principal investigator · Lütfiye Nuri Burat Goverment Hastanesi

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion